Pacific biosciences of california stock price

Pacific Biosciences of California, Inc. Common Stock (PACB) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.

Pacific Biosciences of California (NASDAQ:PACB) shares rose 5.1% during trading on Wednesday . The stock traded as high as $5.42 and last traded at $5.34, approximately 958,882 shares traded hands during mid-day trading. A decline of 41% from the average daily volume of 1,622,771 shares. The stock had previously closed at $5.08. A number of […] PACB Stock News and Price / Pacific Biosciences of ... PACB / Pacific Biosciences of California, Inc. / FEINBERG LARRY N - SC 13G/A Passive Investment. 20h sec.gov UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Amendment No. 6* Under the Securities Exchange Act of 1934 Accelerate Diagnostics, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 69404D108 (CUSIP Number) … PACB Pacific Biosciences of California, Inc. — Stock Price ... Real-time trade and investing ideas on Pacific Biosciences of California, Inc. PACB from the largest community of traders and investors. Market Data by Xignite and BATS BZX Real-Time Price. LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, Pacific Biosciences of California, Inc. - TheStreet

MENLO PARK, Calif. and DAVIS, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- The Earth BioGenome Project (EBP) and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high

Pacific Biosciences of Californ (PACB) Stock Price, Quote ... Pacific Biosciences of California, Inc. (PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, announced that the jury verdict in the U.S. District Court Pacific Biosciences of California, Inc. Common Stock (PACB ... Pacific Biosciences of California, Inc. Common Stock (PACB) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Pacific Biosciences Of California, Inc. - PACB - Stock ... View Pacific Biosciences of California, Inc. PACB investment & stock information. Get the latest Pacific Biosciences of California, Inc. PACB detailed stock quotes, stock data, Real-Time ECN

Pacific Biosciences of California, Inc. Common Stock (PACB) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.

Mar 27, 2020 · Learn about PACB with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to …

Pacific Biosciences of California Inc., PACB Quick Chart ...

Get breaking news and analysis on Pacific Biosciences of California, Inc. (PACB) stock, price quote and chart, trading and investing tools. Pacific Biosciences of Californ (PACB) Stock Historical ... Discover historical prices for PACB stock on Yahoo Finance. View daily, weekly or monthly format back to when Pacific Biosciences of Californ stock was issued.

12 days ago · The new note on the price target was released on October 15, 2019, representing the official price target for Pacific Biosciences of California Inc. stock. Previously, the target price had yet another raise from $4.50 to $8, while Stephens kept a Equal-Weight rating on PACB stock.

Real-time trade and investing ideas on Pacific Biosciences of California, Inc. PACB from the largest community of traders and investors. Market Data by Xignite and BATS BZX Real-Time Price. LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, Pacific Biosciences of California, Inc. - TheStreet Pacific Biosciences Of California, Inc. Fourth Quarter 2019 Financial Results Call Pacific Bio shares fall on U.K. antitrust concern about Illumina deal Today's Perilous Reversal Stock Pacific Biosciences of California Inc. [PACB] stock ... 12 days ago · The new note on the price target was released on October 15, 2019, representing the official price target for Pacific Biosciences of California Inc. stock. Previously, the target price had yet another raise from $4.50 to $8, while Stephens kept a Equal-Weight rating on PACB stock.

Pacific Biosciences of California (NASDAQ:PACB) Stock ...